Navigation Links
Palomar to Unveil New Laser-Assisted Liposuction Platform at the American Society for Laser Medicine & Surgery
Date:3/28/2008

m)

About Palomar Medical Technologies Inc.: Palomar is a leading researcher and developer of light-based systems for cosmetic treatments. Palomar pioneered the optical hair removal field, when, in 1997, it introduced the first high-powered laser hair removal system. Since then, many of the major advances in light-based hair removal have been based on Palomar technology. In December 2006, Palomar became the first company to receive a 510(k) over-the- counter (OTC) clearance from the United States Food and Drug Administration (FDA) for a new, patented, home use, light-based hair removal device. OTC clearance allows the product to be marketed and sold directly to consumers without a prescription. There are now millions of light-based cosmetic procedures performed around the world every year in physician offices, clinics, spas and salons. Palomar is testing many new and exciting applications to further advance the hair removal market and other cosmetic applications. Palomar is focused on developing proprietary light-based technology for introduction to the mass markets. Palomar has granted The Procter & Gamble Company a non-exclusive License Agreement to certain patents, technology and FDA documents related to the home-use, light-based hair removal field for women. In addition, Palomar has an exclusive development and license agreement with Johnson & Johnson Consumer Companies to develop and potentially commercialize home-use, light-based devices for reducing or reshaping body fat including cellulite, reducing the appearance of skin aging, and reducing or preventing acne.

For more information on Palomar and its products, visit Palomar's website at http://www.palomarmedical.com . To continue receiving the most up-to-date information and latest news on Palomar as it happens, sign up to receive automatic e-mail alerts by going to the Investor Relations' section of the website.

This press release
'/>"/>

SOURCE Palomar Medical Technologies Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. Palomar Medical Technologies Third Quarter 2007 Financial Results Conference Call and Webcast
2. Palomar and Gillette Extend Launch Decision on Home-Use Light Based Hair Removal Device and Agree to Negotiate New Terms
3. Palomar to Debut New Technology at the American Academy of Dermatology Annual Meeting
4. Palomar Seeks to License Additional Companies to Home-Use Light-Based Hair Removal Technology
5. ARIZONA METH PROJECT Unveils Arizonas Anti-Meth Youth Pledge and Kicks Off Phase Two of Public Awareness Campaign
6. Wellcorps International Unveils New Nutritional Supplements
7. Edwards Plan on AIDS Unveiled Today
8. The Village Company Unveils Natural Bath and Body Solutions for Everyday Ailments
9. Rice unveils $100 million initiative for world health technology
10. Medco Unveils Three New Medicare Prescription Drug Plan Options for 2008 to Provide Seniors More Choice, Better Value and Specialist Pharmacists
11. Aloka to Unveil New ProSound Diagnostic Ultrasound System at the 17th World Congress on Ultrasound in Obstetrics and Gynecology, 7th to 11th of October 2007 in Florence, Italy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2013)... General Data Company Inc., a leading ... data management products and solutions, has announced that ... of Durham, North Carolina, a leading manufacturer and ... clinical and research pathology marketplace. TBS will become ... specialty products and solutions to hospitals, independent labs ...
(Date:5/24/2013)... first conference of its kind, Impacts World 2013 ... decision makers from politics, business and civil society ... climate impact research across sectors and scales. , ... 2013 on May 27th, 1pm to 1:55pm and ... Speakers include: , Connie Hedegaard, EU ...
(Date:5/24/2013)... can healthy people who hear voices help schizophrenics? Finding the ... at the University of Bergen. , Researchers from the Bergen ... on how to help schizophrenics, who hear voices. The way ... voices, but who do not suffer from a mental illness. ... processes causing people to hear voices. A recent report published ...
(Date:5/24/2013)... May 24, 2013 The Icahn School ... International (CDI) exclusive license rights to commercially develop ... medicine applications. These cells are capable of further differentiation ... cardiomyocytes, endothelial cells, and vascular smooth muscle cells, and ... damaged heart tissue. , The original agreement announced in ...
(Date:5/24/2013)... The creative flair and design talent of graduating students ... Textiles and Clothing (ITC) have won applause from the ... 22 May at The Mira Hong Kong. ... various knitwear producers and yarn suppliers, the annual Knitwear ... from 20 graduating students majoring in knitwear design. The ...
Breaking Medicine News(10 mins):Health News:General Data Acquires Triangle Biomedical Sciences 2Health News:General Data Acquires Triangle Biomedical Sciences 3Health News:Help at hand for schizophrenics 2Health News:Icahn School of Medicine at Mount Sinai Grants Exclusive License to Cellular Dynamics International for Development of a Cellular Therapy for Cardiac Muscles 2Health News:Icahn School of Medicine at Mount Sinai Grants Exclusive License to Cellular Dynamics International for Development of a Cellular Therapy for Cardiac Muscles 3Health News:Icahn School of Medicine at Mount Sinai Grants Exclusive License to Cellular Dynamics International for Development of a Cellular Therapy for Cardiac Muscles 4Health News:PolyU Stages Knitwear Fashion Show 2
... from Strong International Performance and InLight ... Equipment Sales, ... personal and environmental radiation,monitoring, today reported record performance in its first fiscal ... -- Revenue reached a record $21.8 million on higher international revenues ...
... Sensitive Customer Health Care ... Data on Laptops and Desktops, ... global,leader in enterprise data protection, today announced that Payformance,Health, a ... Funds Transfer (EFT) and Electronic Remittance,Advice (ERA) services, has standardized ...
... Enables Improved Patient Safety and Office ... ... Jan. 31 Kryptiq, the leading provider,of next generation healthcare ... A four-hospital,organization with 55 physician clinics in the Springfield, MO ...
... 31 Oncology focused,biopharmaceutical product development company ... finalized its Rhitol(TM) Phase II clinical trial,with ... treatment cycle. Rhitol(TM),is evaluated as treatment for ... (GvHD) intolerant or resistant to standard immunosuppressive,treatment., ...
... ... -- Revises 2008 EPS Guidance Primarily to Reflect the Sale of Medical ... Imaging, -- Reaffirms Expected Non-GAAP EPS CAGR of at ... Through 2010, Subject to Certain Assumptions, -- Completes Sale of Medical Imaging Business, Reports as Discontinued, ...
... 31, 2008 The Procter &,Gamble Company (NYSE: ... to,$21.6 billion for the quarter. Sales were up behind ... and double-digit organic,growth in developing regions. Organic volume increased ... the quarter. Diluted earnings per,share increased 17 percent to ...
Cached Medicine News:Health News:Landauer, Inc. Reports Strong Fiscal 2008 First Quarter Results 2Health News:Landauer, Inc. Reports Strong Fiscal 2008 First Quarter Results 3Health News:Landauer, Inc. Reports Strong Fiscal 2008 First Quarter Results 4Health News:Landauer, Inc. Reports Strong Fiscal 2008 First Quarter Results 5Health News:Landauer, Inc. Reports Strong Fiscal 2008 First Quarter Results 6Health News:Landauer, Inc. Reports Strong Fiscal 2008 First Quarter Results 7Health News:Health Care Solutions Provider Payformance Health Standardizes on PGP Encryption for Data Security 2Health News:Health Care Solutions Provider Payformance Health Standardizes on PGP Encryption for Data Security 3Health News:Health Care Solutions Provider Payformance Health Standardizes on PGP Encryption for Data Security 4Health News:CoxHealth Deploys Kryptiq ePrescribing Solution 2Health News:CoxHealth Deploys Kryptiq ePrescribing Solution 3Health News:Bristol-Myers Squibb Company Reports Financial Results for the Fourth Quarter and Twelve Months of 2007 2Health News:Bristol-Myers Squibb Company Reports Financial Results for the Fourth Quarter and Twelve Months of 2007 3Health News:Bristol-Myers Squibb Company Reports Financial Results for the Fourth Quarter and Twelve Months of 2007 4Health News:Bristol-Myers Squibb Company Reports Financial Results for the Fourth Quarter and Twelve Months of 2007 5Health News:Bristol-Myers Squibb Company Reports Financial Results for the Fourth Quarter and Twelve Months of 2007 6Health News:Bristol-Myers Squibb Company Reports Financial Results for the Fourth Quarter and Twelve Months of 2007 7Health News:Bristol-Myers Squibb Company Reports Financial Results for the Fourth Quarter and Twelve Months of 2007 8Health News:Bristol-Myers Squibb Company Reports Financial Results for the Fourth Quarter and Twelve Months of 2007 9Health News:Bristol-Myers Squibb Company Reports Financial Results for the Fourth Quarter and Twelve Months of 2007 10Health News:Bristol-Myers Squibb Company Reports Financial Results for the Fourth Quarter and Twelve Months of 2007 11Health News:Bristol-Myers Squibb Company Reports Financial Results for the Fourth Quarter and Twelve Months of 2007 12Health News:Bristol-Myers Squibb Company Reports Financial Results for the Fourth Quarter and Twelve Months of 2007 13Health News:Bristol-Myers Squibb Company Reports Financial Results for the Fourth Quarter and Twelve Months of 2007 14Health News:Bristol-Myers Squibb Company Reports Financial Results for the Fourth Quarter and Twelve Months of 2007 15Health News:Bristol-Myers Squibb Company Reports Financial Results for the Fourth Quarter and Twelve Months of 2007 16Health News:Bristol-Myers Squibb Company Reports Financial Results for the Fourth Quarter and Twelve Months of 2007 17Health News:Bristol-Myers Squibb Company Reports Financial Results for the Fourth Quarter and Twelve Months of 2007 18Health News:Bristol-Myers Squibb Company Reports Financial Results for the Fourth Quarter and Twelve Months of 2007 19Health News:Bristol-Myers Squibb Company Reports Financial Results for the Fourth Quarter and Twelve Months of 2007 20Health News:Bristol-Myers Squibb Company Reports Financial Results for the Fourth Quarter and Twelve Months of 2007 21Health News:Bristol-Myers Squibb Company Reports Financial Results for the Fourth Quarter and Twelve Months of 2007 22Health News:Bristol-Myers Squibb Company Reports Financial Results for the Fourth Quarter and Twelve Months of 2007 23Health News:Bristol-Myers Squibb Company Reports Financial Results for the Fourth Quarter and Twelve Months of 2007 24Health News:Bristol-Myers Squibb Company Reports Financial Results for the Fourth Quarter and Twelve Months of 2007 25
(Date:5/23/2013)... TARRYTOWN, N.Y. , May 23, 2013 /PRNewswire/ ... reconstruction following mastectomy is an appropriate option ... mutations seeking to surgically reduce their breast cancer ... involves a gradual expansion process and a second ... of implants in the same surgery as mastectomy ...
(Date:5/23/2013)... -- BioElectronics Corporation (OTC Pink: BIEL), the maker of very ... panel meeting for non-thermal shortwave diathermy: The ... Meeting was held on May 21, 2013 in ... the meeting was very narrow, in that the FDA ... application of non-thermal shortwave diathermy for the treatment of ...
(Date:5/23/2013)... , May 23, 2013  Datameer announced today ... enable data discovery on their big data platform. ... tools they need to quickly and easily visualize ... A Fortune 19 company, Cardinal Health is ... It provides pharmaceuticals and medical products to more ...
Breaking Medicine Technology:Direct to Implant ("One Step") Mastectomy Breast Reconstruction Reduces Number of Surgeries and Time to Final Cosmetic Results 2Direct to Implant ("One Step") Mastectomy Breast Reconstruction Reduces Number of Surgeries and Time to Final Cosmetic Results 3BioElectronics and Pulsed Shortwave Therapy Make Progress 2Cardinal Health Selects Datameer for Healthcare Data Discovery 2
... , , , ... AMGN ) today announced positive top-line results from a pivotal ... acid) administered as an intravenous (IV) infusion in the treatment of ... including breast and prostate cancer) or multiple myeloma. , ...
... , , , , ... Institute (KLRI) has published two new publications on hormone therapies and ... adults. , , Cardiovascular disease caused by atherosclerosis, ... greatest single killer of American women--40% of total deaths--and the rate ...
Cached Medicine Technology:Amgen Announces Positive Top-Line Results for Denosumab in Trial for Delay of Skeletal Related Events in Bone Metastases Patients Compared to Zometa(R) 2Amgen Announces Positive Top-Line Results for Denosumab in Trial for Delay of Skeletal Related Events in Bone Metastases Patients Compared to Zometa(R) 3Amgen Announces Positive Top-Line Results for Denosumab in Trial for Delay of Skeletal Related Events in Bone Metastases Patients Compared to Zometa(R) 4Amgen Announces Positive Top-Line Results for Denosumab in Trial for Delay of Skeletal Related Events in Bone Metastases Patients Compared to Zometa(R) 5Amgen Announces Positive Top-Line Results for Denosumab in Trial for Delay of Skeletal Related Events in Bone Metastases Patients Compared to Zometa(R) 6Amgen Announces Positive Top-Line Results for Denosumab in Trial for Delay of Skeletal Related Events in Bone Metastases Patients Compared to Zometa(R) 7Amgen Announces Positive Top-Line Results for Denosumab in Trial for Delay of Skeletal Related Events in Bone Metastases Patients Compared to Zometa(R) 8TWO NEW KLRI PEER-REVIEWED PUBLICATIONS: Hormone Therapy May Reduce Atherosclerosis in Women Close to Menopause; Growth Hormone May Increase Risk of Diabetes, Improve Lipid Profile in Men 2TWO NEW KLRI PEER-REVIEWED PUBLICATIONS: Hormone Therapy May Reduce Atherosclerosis in Women Close to Menopause; Growth Hormone May Increase Risk of Diabetes, Improve Lipid Profile in Men 3
Straight shafts with fine pierse type tips. Flat open serrated handle with dull finish....
Straight shafts with micro Pierse type tips. Flat open serrated handle, dull finish....
Micro pierse type tips with 2 mm angled Colibri style jaws. Flat open serrated handle, dull finish....
5 mm jaws with teeth provide secure fixation of occular structures....
Medicine Products: